PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of ijpharsciHomeCurrent issueInstructionsArchives
 
Indian J Pharm Sci. 2010 May-Jun; 72(3): 357–360.
PMCID: PMC3003170

Microwave Assisted Synthesis and Biological Activity of Novel Coumarinyltriazolothiadiazoles

Abstract

A series of new 3-(4-methylcoumarinyl-7-oxymethyl)-6-substitutedphenyl-5,6-dihydro-s-triazolo (3,4-b)(1,3,4)-thiadiazoles 2(a-j) have been synthesized by reacting 5-(4-methyl coumarinyl-7-oxymethyl)-4-amino-3-mercapto(4H)-1,2,4-triazole with various aromatic aldehydes by microwave assisted organic synthesis. The structure of the compounds 2 (a-j) has been confirmed by IR, 1H NMR and mass spectral data. All the compounds were screened for antimicrobial and antioxidant activity. Among the compounds tested, compounds 2d (4-dimethyl amino phenyl derivative) and 2h (3,4-dimethoxy phenyl derivative) showed better antimicrobial and antioxidant activity than rest of the compounds in the series.

Keywords: Antimicrobial, coumarin, thiadiazole, Schiff’s base, triazole

Coumarins possess antimicrobial[1,2], antiviral[3], antipyretic[4], antiinflammatory[5] and antioxidant activities[1,2]. Triazolothiadiazoles have been reported to be associated with various biological activities such as antibacterial[1], antiinflammatory[6], analgesic[7] and CNS depressant[8] activity. In the light of these interesting biological activities, we have attempted to synthesize some new triazolothiadiazole derivatives bearing coumarin moiety and test the new compounds for antibacterial, antifungal and antioxidant activity. In our earlier work[2] we had reported the synthesis of 5-(4-methyl coumarinyl-7-oxymethyl)-4-amino-3-mercapto (4H)- 1, 2, 4 -triazole (1). In continuation of the previous work, certain 3-(4-methylcoumarinyl-7-oxymethyl)-6-substitutedphenyl-5,6-dihydro-s-triazolo (3,4-b) (1, 3, 4)-thiadiazoles 2(a-j) have been synthesized by reacting 5-(4-methyl coumarinyl-7-oxymethyl)-4-amino-3-mercapto (4H)- 1, 2, 4 -triazole with various aromatic aldehydes. For the present synthetic work we had opted for microwave irradiation technique, since our previous synthetic work[1,9] using microwave irradiation could bring about a remarkable reduction in the reaction time and gave increased yield of products when compared to conventional heating methods of synthesis. The structures of the synthesized compounds were assigned on the basis of IR, 1H NMR and mass spectral data. The synthesized compounds have been screened for their in vitro antimicrobial, antifungal and antioxidant activity.

Melting points were determined in open capillary tubes and are uncorrected. All the chemicals and solvents used were of laboratory grade and solvents were purified by suitable methods. IR spectra (KBr, cm-1) were recorded on a Jasco FT/IR-410 spectrometer. 1H NMR spectra was recorded in DMSO-d6using TMS as internal standard at IICT, Hyderabad, India. Mass spectra were recorded at IIT Chennai, India. Reactions were carried out in a Daewoo KOG-370A domestic microwave oven at 2450 MHz. The purity of the products was checked using TLC (Silica Gel-G, Merck).

As shown in Scheme 1, the synthesis of 3-(4-methylcoumarinyl-7-oxymethyl)-6-substitutedphenyl-5,6-dihydro-s-triazolo (3,4-b) (1,3,4)-thiadiazoles[1] 2(a-j) was carried out by taking a mixture of 5-(4-methyl coumarinyl-7-oxymethyl)-4-amino-3-mercapto (4H)-1,2,4-triazole (1) (3.04 g, 0.01 mol), substituted benzaldehyde (0.01 mol), p-toluene sulphonic acid (30 mg) and DMF (15 ml) in 100 ml borosil beaker, which was zapped inside a microwave oven for period of 3-4 min at 100% power. The reaction mixture was cooled and poured over ice cold water. The product so obtained was filtered, washed with water, dried and recrystallized using dimethyl formamide. The purity was established by a single spot on TLC plate. The solvent system used was chloroform:acetone (5:5). The characterization data of synthesized compounds are given in Table 1.

TABLE 1
CHARACTERIZATION DATA OF THE SYNTHESISED COMPOUNDS
Scheme 1
Synthesis of coumarinyltriazolothiadiazoles General method of synthesis of 3-(4-methylcoumarinyl-7-oxymethyl)-6-substitutedphenyl-5, 6-dihydro-s-triazolo (3, 4-b) (1, 3, 4)-thiadiazoles 2(a-j)

5b: IR (KBr)cm-1: 3434 (N-H), 1702 (C=O), 1606 (C=C),1519 (C-NO2), 1268 (C-O-C); 728 (N-C-S), 1H NMR (DMSO-d6) δ ppm: 3.4 (s, 3H, CH3), 5.4 (s, 2H, CH2), 6.9-7.1 (d, 1H, CH-thiadiazole), 7.2-8.6 (m, 8H, Ar-H), 8.6 (d, 1H, NH). Mass (m/z): 436 (M-1)+, 422, 391, 149.

Antimicrobial activity was determined using disc diffusion method[10] by measuring the inhibition zone in mm. All the compounds 2(a-j) were screened in vitro for antibacterial activity against Staphylococcus aureus and Escherichia coli and antifungal activity against Candida albicans at 500 μg/ml. Standard antibacterial drug ciprofloxacin and antifungal drug fluconazole at 10 μg/disc were also tested under similar conditions and these compounds showed highest activity (23-28 mm) against all these organisms tested. The data of compounds with their activity are given in Table 2.

TABLE 2
ANTIMICROBIAL AND ANTIOXIDANT ACTIVITY DATA OF THE SYNTHESISED COMPOUNDS

The compounds synthesized were evaluated for antioxidant activity and compared with standard drug (ascorbic acid). The activity was evaluated using the DPPH method[9]. One millilitre of 0.3 mM DPPH ethanol solution was added to 2.5 ml of sample solutions of different concentrations (2, 4, 6, 8 and 10 μg/ml) and allowed to react at room temperature. After 30 min the absorbance values were measured at 518 nm and converted into the percentage antioxidant activity (AA) using the formula, AA% = 100–(Abssample–Absblank)×100/Abscontrol).

Ethanol (1.0 ml) plus drug solution (2.5 ml) was used as a blank. DPPH solution (1.0 ml, 0.3 mM) plus ethanol (2.5 ml) was used as a negative control. The positive controls were those using the standard solution (ascorbic acid). The IC50 values were calculated by linear regression plots, where abscissa represented the concentration of test drug solution (2, 4, 6, 8 and 10 μg/ml) and ordinate the average percent of antioxidant activity from three separate tests. The results are tabulated in Table 2.

All compounds were in conformity with the structures envisaged. The structures were proved on the basis of spectral data. Among the newly synthesized compounds showing antibacterial and antifungal activity, it was observed that compound 2b (3-nitrophenyl derivative) showed highest degree of antibacterial activity against Staphylococcus aureus and Escherichia coli. Compounds 2b (3-nitrophenyl derivative), 2h (3,4-dimethoxyphenyl derivative) and 2j (4-hydroxy-3-ethoxyphenyl derivative) showed better antifungal activity than rest of the newly synthesised compounds. Compounds 2d (4-dimethylaminophenyl derivative) and 2f (4-chlorophenyl derivative) showed moderate activity against Staphylococcus aureus and Escherichia coli. Rest of the compounds showed either minimal activity or no antimicrobial activity. In antioxidant studies, compounds 2d (IC50-5.7 μg/ml) (4-dimethylaminophenyl derivative) and 2h (IC50-5.6 μg/ml) (3,4-dimethoxyphenyl derivative) were identified to be more potent than rest of the compounds. From the results of biological screening we could conclude that 3,4-dimethoxyphenyl substituent and 4-N,N-dimethylphenyl substituent at position 6 of triazolothiadiazole are vital in improving the scavenging capacity of free radicals as evident from the antioxidant activity of compounds 2h and 2d, respectively which was comparable to that of standard ascorbic acid. Similarly the results of antimicrobial screening showed that substitution of 3-nitrophenyl substituent at position 6 of triazolothiadiazole confers both antibacterial and antifungal activity as seen with compound 2b. The compounds 2d and 2h can be chosen as lead moieties for antimicrobial and antioxidant studies and compounds 2b, 2j and 2f for antimicrobial studies.

Acknowledgments

The authors are thankful to Managing Trustee, SNR Sons Charitable trust, Dr. R. Venkatesalu Naidu for providing necessary laboratory facilities to carry out this research work.

Footnotes

Kumar, et al.: Synthesis and Biological Activity of Novel Coumarinyltriazolothiadiazoles

REFERENCES

1. Kumar MP, Mazumder J, Chawla R, Bhuvana S, George S, Gopalakrishan S, et al. Microwave assisted synthesis of 3,6-disubstituted-5,6-dihyro-s-triazolo (3,4-b) (1,3,4)-thiadiazoles and their biological activities. Indian J Heterocycl Chem. 2008;17:263–64.
2. Kumar MP, Ravi TK, Gopalakrishnan S, Bhat AR, Chawla R, George S, et al. Synthesis of certain 5-substituted-4-arylideneamino-3-mercapto-(4H)-1,2,4-triazoles and 1-substituted-4-arylidene-3-methyl-5-pyrazolones and their antimicrobial and antioxidant activities. Indian Drugs. 2008;45:626–30.
3. Bishnoi A, Saxena R. Synthesis of hexahydro-1,3,5-tri (8-aryl-aminomethyl-7-hydroxy-4-methyl quinolinyl)-s-triazine as possible antiviral agents. Indian J Heterocycl Chem. 2001;11:47–50.
4. Shastri AL, Ghate DM, Kulkarni VM. Dual fluorescence and biological evaluation of paracetamol ethers from 4-bromomethylcoumarin. Indian J Chem. 2004;43B:2416–22.
5. Ghate M, Manohar D, Kulkarni V, Shoba R. Synthesis of vanillin ethers from 4-(bromomethyl) coumarins as anti-inflammatory agents. Eur J Med Chem. 2003;38:297–302. [PubMed]
6. Gupta R, Sudan S, Kachroo PL. Reaction of 3-substituted-4-amino-s-mercapto-1,2,4-triazoles with substituted cinnamic acid. Indian J Chem. 1996;35B:718–20.
7. Udupi RH, Setty SR, Srinivasulu N. Synthesis of condensed triazole system and their biological evaluation. Indian Drugs. 2002;39:318–21.
8. Gupta R, Paul S, Gupta AK, Kachroo PL. Improved synthesis of some substituted 5,6-dihydro-s-triazolo (3,4-b) (1,3,4)-thiadiazoles in a microwave oven. Indian J Chem. 1994;33B:888–91.
9. Kumar MP, Ravi TK, Lakshmimadhuri M, Chawla R, Sonia G, Gopalakrishnan S. Microwave assisted synthesis of 3,5-dimethyl-4-(arylazo)pyrazoles and isoxazoles over conventional method and their therapeutic activities. Indian Drugs. 2009;46:384–90.
10. Bauer AN, Kirby WNM, Sherries JC, Truck M. Antibiotic susceptibility testing by a standardised single disc method. Amer J Clin Path. 1996;45:493–96. [PubMed]

Articles from Indian Journal of Pharmaceutical Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications